Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Asset Utilization Ratio (2016 - 2026)

Aytu Biopharma has reported Asset Utilization Ratio over the past 12 years, most recently at 0.51 for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 4.17% to 0.51 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.51 through Dec 2025, down 4.17% year-over-year, with the annual reading at 0.55 for FY2025, 7.0% up from the prior year.
  • Asset Utilization Ratio was 0.51 for Q4 2025 at Aytu Biopharma, down from 0.51 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.76 in Q2 2023 and troughed at 0.3 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.55 (2024), against an average of 0.58.
  • Year-over-year, Asset Utilization Ratio soared 137.29% in 2022 and then crashed 30.28% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.37 in 2021, then skyrocketed by 95.56% to 0.72 in 2022, then dropped by 5.92% to 0.68 in 2023, then dropped by 22.36% to 0.53 in 2024, then decreased by 4.17% to 0.51 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Asset Utilization Ratio are 0.51 (Q4 2025), 0.51 (Q3 2025), and 0.53 (Q2 2025).